ADHD and the paediatrician: A guide to management

Current Paediatrics

Volumn 15, Issue 2, 2005, Pages 133-142

  Keen, Daphne V ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

ADHD; Adolescent; Child; Co morbidity; Drug therapy

Indexed keywords

AMFEBUTAMONE; ATOMOXETINE; CLOMIPRAMINE; CLONIDINE; DESIPRAMINE; DEXAMPHETAMINE; EQUASYM; IMIPRAMINE; MELATONIN; METHYLPHENIDATE; PIMOZIDE; RISPERIDONE; SULPIRIDE; TRICYCLIC ANTIDEPRESSANT AGENT;

AGGRESSION; ANOREXIA; ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; BEHAVIOR THERAPY; BRAIN INJURY; COMORBIDITY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; DYSCALCULIA; DYSLEXIA; EPILEPSY; FETAL ALCOHOL SYNDROME; FRAGILE X SYNDROME; GENETIC DISORDER; HAPPY PUPPET SYNDROME; HUMAN; LANGUAGE; LEARNING DISORDER; MENTAL DEFICIENCY; MENTAL DISEASE; MOOD DISORDER; MOTOR PERFORMANCE; PEDIATRICIAN; PRADER WILLI SYNDROME; PRENATAL EXPOSURE; SIDE EFFECT; SLEEP DISORDER; SMITH MAGENIS SYNDROME; SOCIAL ADAPTATION; SYMPTOM; TIC; VELOCARDIOFACIAL SYNDROME;

EID: 14844363631     PISSN: 09575839     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cupe.2004.12.001     Document Type: Article

References (46)

1. J. Biederman, T. Spencer, and T. Wilens Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder Int J Neuropsychopharmacol 7 2004 77 97
2. P. Roy, M. Rutter, and A. Pickles Institutional care associations between overactivity and lack of selectivity in social relationships J Child Psychol Psychiatry 45 2004 866 873
3. J. Biederman, S.V. Faraone, and M.C. Monuteaux Differential effect of environmental adversity by gender Rutter's index of adversity in a group of boys and girls with and without ADHD Am J Psychiatry 159 2002 1556 1562
4. E. Mick, J. Biederman, S.V. Faraone, J. Sayer, and S. Kleinman Case-control study of attention-deficit hyperactivity disorder and maternal smoking, alcohol use, and drug use during pregnancy J Am Acad Adolesc Psychiatry 41 2002 378 385
5. A.J. Kotimaa, I. Moilanen, and A. Taanila Maternal smoking and hyperactivity in 8-year-old children J Am Acad Adolesc Psychiatry 42 2003 826 833
6. A. Ornoy, J. Segal, R. Bar-Hamburger, and C. Greenbaum Developmental outcome of school-age children born to mothers with heroin dependency importance of environmental factors Dev Med Child Neurol 43 2001 668 675
7. The MTA cooperative group A 14-month randomized clinical trial of treatment strategies for attention-deficit hyperactivity disorder. Multimodal Treatment Study of Children with ADHD Arch Gen Psychiatry 56 1999 1073 1086
8. R.G. Klein, H. Abikoff, L. Hechtman, and G. Weiss Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD J Am Acad Adolesc Psychiatry 43 2004 792 801
9. National Institute for Clinical Excellence. Guidance on the use of methylphenidate (Ritalin, Equasym) for attention deficit hyperactivity disorder (ADHD) in childhood. London: NICE; 2000.
10. T.E. Wilens, J. Biederman, and S. Brown Psychiatric comorbidity and functioning in clinically referred preschool children and school-aged youths with ADHD J Am Acad Adolesc Psychiatry 41 2001 262 268
11. A.R. Barkley Attention-deficit hyperactivity disorder 2nd ed 1998 The Guilford Press New York, NY
12. M. Gaub, and C.L. Carlson Gender differences in ADHD a meta-analysis and critical review J Am Acad Adolesc Psychiatry 36 1997 1036 1045
13. E. Mick, S.V. Faraone, and J. Biederman Age-dependant expression of attention deficit/hyperactivity disorder symptoms Psychiatr Clin N Am Spec Issue 27 2004 215 224
14. B. Kadesjö, and C. Gillberg The comorbidity of ADHD in the general population of Swedish school aged children J Child Psychol Psychiatry 42 2001 487 492
15. P.S. Jensen, S.P. Hinshaw, and H.C. Kraemer ADHD comorbidity findings from the MTA study comparing comorbid subgroups J Am Acad Adolesc Psychiatry 40 2001 147 158
16. S.R. Pliszka Psychiatric comorbidities in children with attention deficit hyperactivity disorder implications for management Paediatr Drugs 5 2003 741 750
17. D.G. Sukhodolsky, L. Scahill, and H. Zhang Disruptive behavior in children with Tourette's syndrome association with ADHD comorbidity, Tic severity, and functional impairment J Am Acad Adolesc Psychiatry 42 2003 98 105
18. H. Sturm, E. Fernell, and C. Gillberg Autism spectrum disorders in children with normal intellectual levels associated impairments and subgroups Dev Med Child Neurol 46 2004 444 447
19. D.V. Keen, and S. Ward Autistic spectrum disorder a child population profile Autism 8 2004 39 48
20. J. Gilmour, B. Hill, M. Place, and D.H. Skuse Social communication deficits in conduct disorder a clinical and community survey J Child Psychol Psychiatry 45 2004 967 978
21. Block GW. Diagnostic subgroups and neuropsychological attention deficits in fetal alcohol syndrome, Dissertation Abstracts International: Section B: the Sciences and Engineering, vol. 62. Ann Arbor, MI: University Microfilms International; 2002. p. 5362.
22. R.J. Hagerman Psychopharmacological interventions in Fragile X syndrome, fetal alcohol syndrome, Prader-Willi syndrome, Angelman syndrome, Smith-Magenis syndrome, and velocardiofacial syndrome Mental Retard Dev Disab Res Rev 5 1999 305 313
23. V.F. Mautner, L. Kluwe, S.D. Thakker, and R.A. Leark Treatment of ADHD in neurofibromatosis type I Dev Med Child Neurol 44 2002 164 170
24. D. Dunn, J.K. Austin, J. Harezlak, and W.T. Ambrosius ADHD and epilepsy in childhood Dev Med Child Neurol 45 2003 50 54
25. I. Elgen, K. Sommerfelt, and T. Markestad Population based, controlled study of behavioural problems and psychiatric disorders in low birthweight children at 11 yrs of age Arch Dis Child Neonatal Ed 87 2002 F128 F132
26. J.P. Gerring, K.D. Brady, and A. Chen Premorbid prevalence of ADHD and development of secondary ADHD after closed head injury J Am Acad Adolesc Psychiatry 37 1998 647 654
27. P. Rasmussen, and C. Gillberg Natural outcome of ADHD with developmental coordination disorder at age 22 years a controlled longitudinal, community-based study J Am Acad Child Adolesc Psychiatry 39 2000 1424 1431
28. S. Taylor, J. Sergeant, and M. Doepfner Clinical guidelines for hyperkinetic disorder Eur Child Adolesc Psychiatry 7 1998 184 200
29. American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of children, adolescents and adults with attention-deficit hyperactivity disorder. ADHD practice parameters J Am Acad Adolesc Psychiatry 36 1997 S85 S121
30. American Academy of Child and Adolescent Psychiatry Practice parameters for the use of stimulant medications in the treatment of children, adolescents, and adults J Am Acad Adolesc Psychiatry 41 2002 26S 49S
31. C.K. Conners Conners' Rating Scales - revised 1997 Multi-Health Systems Toronto
32. Barkley RA. Behavior rating scales. In: Attention-deficit/hyperactivity disorder: a handbook for diagnosis and treatment. New York: Guilford; 1990. p. 278-326.
33. G. Du Paul, T.J. Power, A.D. Anastopoulos, and R. Reid ADHD rating scales - IV checklists, norms and clinical interpretation 1998 Guilford New York
34. S. Kutcher, M. Aman, and S.J. Brooks International consensus statement on attention-deficit/hyperactivity disorder and disruptive behavior disorders (DBDs) clinical implications and treatment practice suggestions Eur Neuropsychopharmacol 14 2004 11 28
35. B. Bateman, J.O. Warner, and E. Hutchinson The effects of a double-blind, placebo-controlled, artificial food colourings and benzoate preservative challenge on hyperactivity in a general population sample of pre-school children Arch Dis Child 89 2004 506 511
36. D. Michelson, A.J. Allen, and J. Busner Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder a randomized, placebo-controlled study Am J Psychiatry 159 2002 1896 1901
37. C.K. Conners, C.D. Casat, and C.T. Gualtieri Bupropion hydrochloride in attention deficit disorder with hyperactivity J Am Acad Adolesc Psychiatry 35 1996 1314 1321
38. D.F. Conner Preschool attention deficit hyperactivity disorder a review of prevalence, diagnosis, neurobiology, and stimulant treatment J Dev Behav Pediatr 23 Suppl. 1 2002 S1 S9
39. Lynch JN, Cooper KM, Gu J, May LG. OROS MPH mg-kg dosing: therapy in adolescents with ADHD. A poster presented at the American Academy of Child and Adolescent Psychiatry meeting, October 2003. www.aacap.org.
40. K. Gucuyener, A.K. Erdemoglu, S. Senol, A. Serdaroglu, S. Soysal, and A.I. Kockar Use of methylphenidate for attention-deficit hyperactivity disorder in patients with epilepsy or electroencephalographic abnormalities J Child Neurol 18 2003 109 112
41. D.A. Pearson, C.W. Santos, and J.D. Roache Treatment effects of methylphenidate on behavioral adjustment in children with mental retardation and ADHD J Am Acad Adolesc Psychiatry 42 2003 209 216
42. M. Aman Stimulant drugs in the developmental disabilities revisited J Dev Phys Disab 8 1996 347 365
43. J. Coe, J. Sidders, K. Riley, J. Waltermire, and R. Hagerman A survey of medication responses in children and adolescents with fetal alcohol syndrome Mental Health Aspects Dev Disab, Spec Issue 4 2001 148 155
44. C. Jin, and R. Schachar Methylphenidate treatment of attention-deficit/ hyperactivity disorder secondary to traumatic brain injury a critical appraisal of treatment studies CNS Spectrums 9 2004 217 226
45. D.F. Connor, S.J. Glatt, I.D. Lopez, D. Jackson, and R.H. Melloni Psychopharmacology and aggression. 1 a meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD J Am Acad Adolesc Psychiatry 41 2002 253 261
46. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 4th ed 2000 American Psychiatric Association Washington, DC